Discovery of NLX-266, an Orally Available and Metabolically Stable ERK1/2-Biased 5-HT(1A)R Agonist with Superior Antidepressant and Antiparkinsonian Activity
发现 NLX-266,一种口服有效且代谢稳定的 ERK1/2 偏向性 5-HT(1A)R 激动剂,具有优异的抗抑郁和抗帕金森病活性。
期刊:Journal of Medicinal Chemistry
影响因子:6.8
doi:10.1021/acs.jmedchem.5c00484
Sniecikowska, Joanna; Gluch-Lutwin, Monika; Bucki, Adam; Gryzlo, Beata; Wieckowski, Krzysztof; Godyn, Justyna; Wieckowska, Anna; Siwek, Agata; Jastrzebska-Wiesek, Magdalena; Partyka, Anna; Cios, Agnieszka; Wesolowska, Anna; Newman-Tancredi, Adrian; Kolaczkowski, Marcin